External analyst notes, journalism, and industry commentary cited with attribution.
Past catalysts on this ticker, reconciled against the announcement parse pipeline. Hover any row for the parsed outcome detail.
Rexlemestrocel-L's own upcoming catalysts alongside class-defining historical readouts and upcoming primary completion dates in the same mechanism classes. Each event moves the broader thesis for Rexlemestrocel-L. Showing past 6 months and next 12 months · 4 later hidden.
Same axes, same units. Discontinued and historical pivotal trials excluded; see Competitor Landscape below for the full set.
| Trial | Sponsor | Class | Phase / Line | Design | Primary endpoint | Dosing | Key eligibility | n |
|---|---|---|---|---|---|---|---|---|
| Rexlemestrocel-L | Mesoblast | Mesenchymal Stem Cell | Phase 3 | 0 | ||||
| Biofreeze® vs. a Placebo on Chronic Low Back Pain Walking Gait Characteristics and Pain | Sport and Spine Rehab Clinical Research Foundation | — |
Read-across commentary attached per trial. Phase ordering preserved within each group.
"Sponsor guided" dates come from IR materials and earnings calls; hover for the cited source. "CT.gov proxy" dates fall back to the registry primary completion date — actual readouts typically follow by 3-6 months.
| — |
| — |
| — |
| — |
| — |
| The Effect of Pregabalin and Etoricoxib on Pain Alone Versus in Combination | Muhammad Ilyas | — | Phase 4 | — | — | — | — | — |
| Efficacy of ActiveMatrix on Spinal SSI Rate | Baylor College of Medicine | — | Phase 4 | — | — | — | — | — |
| Basivertebral Nerve Ablation With the Intracept Procedure | Neuro Spine and Pain Center of Key West | — | Phase 4 | — | — | — | — | — |
| Percutaneous Electrical Nerve Stimulation As Alternative To Nerve Blocks In Anesthesia, Pain Medicine And Rehabilitation Of Nonspecific Chronic Pain | Universidad Complutense de Madrid | — | Phase 4 | — | — | — | — | — |
| Melatonin fOr CHronic bAck Pain (The MOCHA Trial) | Odense University Hospital | — | Phase 3 | — | — | — | — | — |
| Nonpharmacologic Pain Management in FQHC Primary Care Clinics | University of Utah | — | Phase 3 | — | — | — | — | — |
| Melatonin for Patients With Chronic Low Back Pain | Bart Koes | — | Phase 3 | — | — | — | — | — |
| Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain | Mesoblast, Ltd. | — | Phase 3 | — | — | — | — | — |
| Efficacy of Antibiotic Treatment for Patients With Chronic Low Back Pain and Modic Type I Changes - Randomized Placebo-controlled Trial | Bart Koes | — | Phase 3 | — | — | — | — | — |
| A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain | Eli Lilly and Company | — | Phase 3 | — | — | — | — | — |
| Efficacy and Safety of VER-01 in the Treatment of Patients With Radicular Chronic Low Back Pain | Vertanical GmbH | — | Phase 3 | — | — | — | — | — |
| Functional Restoration for Chronic Low Back Pain: Medico-economic Impact | Assistance Publique - Hôpitaux de Paris | — | Phase 3 | — | — | — | — | — |
| Mechanisms of Stimulation for Pain Alleviation | Stanford University | — | Phase 3 | — | — | — | — | — |
| Veterans' Intervention Blending NeuRomodulation and YogA for Chronic Low BackPaiN Treatment: VIBRANT | VA Office of Research and Development | — | Phase 3 | — | — | — | — | — |
| Efficacy of Intradiscal Injection of BM-MSC in Subjects With Chronic Low Back Pain (LBP) Due to Lumbar Degenerative Disc Disease (DDD) Unresponsive | University Hospital, Montpellier | — | PHASE2/PHASE3 | — | — | — | — | — |
| Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure | Northwestern University | — | Phase 2 | — | — | — | — | — |
| Evaluation of the Benefit and Safety of Localized Tissue Hydration in the Management of Chronic Low Back Pain | GCS Ramsay Santé pour l'Enseignement et la Recherche | — | Phase 2 | — | — | — | — | — |
| Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD | Fondazione Policlinico Universitario Campus Bio-Medico | — | Phase 2 | — | — | — | — | — |
| Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P) | Evon Medics LLC | — | Phase 2 | — | — | — | — | — |
| A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain | Eli Lilly and Company | — | Phase 2 | — | — | — | — | — |
| Modulation Effect of tACS on Chronic Low Back Pain | Massachusetts General Hospital | — | Phase 2 | — | — | — | — | — |
| Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression | VA Office of Research and Development | — | Phase 2 | — | — | — | — | — |
| Dronabinol as an Adjunct for Reducing Pain | Christopher D. Verrico | — | Phase 2 | — | — | — | — | — |
| Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain | Yale University | — | Phase 2 | — | — | — | — | — |
| Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial | VA Office of Research and Development | — | Phase 2 | — | — | — | — | — |
| Resilience Enhancement Following Sleep Treatment | University of Virginia | — | Phase 2 | — | — | — | — | — |
| Psilocybin Therapy for Chronic Low Back Pain | Joshua Woolley, MD, PhD | — | PHASE1/PHASE2 | — | — | — | — | — |
| Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain | Creative Medical Technology Holdings Inc | — | PHASE1/PHASE2 | — | — | — | — | — |